Flaminia Talos

1.1k total citations
19 papers, 834 citations indexed

About

Flaminia Talos is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Flaminia Talos has authored 19 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Biotechnology. Recurrent topics in Flaminia Talos's work include Cancer-related Molecular Pathways (12 papers), Cancer Research and Treatments (6 papers) and Virus-based gene therapy research (3 papers). Flaminia Talos is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Cancer Research and Treatments (6 papers) and Virus-based gene therapy research (3 papers). Flaminia Talos collaborates with scholars based in United States, Germany and Russia. Flaminia Talos's co-authors include Ute M. Moll, Oleksi Petrenko, Ramona Schulz, Dun Li, Talía Velasco-Hernández, Natalia Marchenko, Victoria Fischer, Matthias Dobbelstein, Alice Nemajerová and Michael M. Shen and has published in prestigious journals such as Cell, Nature Communications and Molecular Cell.

In The Last Decade

Flaminia Talos

18 papers receiving 823 citations

Peers

Flaminia Talos

ONCOL

BIOTE

Nathalie Cahuzac France

Penny K. Davis United States

H. Carl Le United States

Florian Wegwitz Germany

Thomas R. Geiger United States

Stéphanie Courtois-Cox France

Yow-Ling Shiue Taiwan

R Ludwig United States

Juliann Shih United States

Evelyne Lima‐Fernandes Canada

Nathalie Cahuzac France

Flaminia Talos

604 ×1.0

467 ×1.1

ONCOL

195 ×1.2

72 ×0.7

BIOTE

188 ×2.4

Citations per year, relative to Flaminia Talos Flaminia Talos (= 1×) peers Nathalie Cahuzac

Countries citing papers authored by Flaminia Talos

Since Specialization

Citations

This map shows the geographic impact of Flaminia Talos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flaminia Talos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flaminia Talos more than expected).

Fields of papers citing papers by Flaminia Talos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flaminia Talos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flaminia Talos. The network helps show where Flaminia Talos may publish in the future.

Co-authorship network of co-authors of Flaminia Talos

This figure shows the co-authorship network connecting the top 25 collaborators of Flaminia Talos. A scholar is included among the top collaborators of Flaminia Talos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flaminia Talos. Flaminia Talos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Rageul, Julie, et al.. (2025). Loss of DNA replication fork protection by TIMELESS degradation supports oncogene-induced senescence. Biochemical and Biophysical Research Communications. 776. 152203–152203.

Szenk, Mariola, et al.. (2023). Immune mechanisms shape the clonal landscape during early progression of prostate cancer. Developmental Cell. 58(12). 1071–1086.e8. 4 indexed citations

Jin, Ting, Nam D. Nguyen, Flaminia Talos, & Daifeng Wang. (2020). ECMarker: interpretable machine learning model identifies gene expression biomarkers predicting clinical outcomes and reveals molecular mechanisms of human disease in early stages. Bioinformatics. 37(8). 1115–1124. 22 indexed citations

Talos, Flaminia, Antonina Mitrofanova, Sarah K. Bergren, Andrea Califano, & Michael M. Shen. (2017). A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue. Nature Communications. 8(1). 14662–14662. 25 indexed citations

Yallowitz, Alisha R., Evguenia M. Alexandrova, Flaminia Talos, et al.. (2014). p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis. Cell Death and Differentiation. 21(4). 645–654. 39 indexed citations

Chen, James C., Mariano J. Alvarez, Flaminia Talos, et al.. (2014). Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks. Cell. 159(2). 402–414. 128 indexed citations

González‐Arnay, Emilio, et al.. (2014). Cortical hypoplasia and ventriculomegaly of p73‐deficient mice: Developmental and adult analysis. The Journal of Comparative Neurology. 522(11). 2663–2679. 20 indexed citations

Li, Dun, Natalia Marchenko, Ramona Schulz, et al.. (2011). Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells. Molecular Cancer Research. 9(5). 577–588. 240 indexed citations

Schulz, Ramona, Flaminia Talos, Andreas H. Scheel, et al.. (2011). While p73 is essential, p63 is completely dispensable for the development of the central nervous system. Cell Cycle. 10(4). 680–689. 22 indexed citations

10.

Talos, Flaminia, Angelina V. Vaseva, Stella E. Tsirka, et al.. (2010). p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis. Cell Death and Differentiation. 17(12). 1816–1829. 93 indexed citations

11.

Talos, Flaminia & Ute M. Moll. (2010). Role of the p53 Family in Stabilizing the Genome and Preventing Polyploidization. Advances in experimental medicine and biology. 676. 73–91. 20 indexed citations

12.

Talos, Flaminia, Ramona Schulz, & Ute M. Moll. (2010). p63 and canonical Wnt signaling. Cell Cycle. 9(4). 642–651. 3 indexed citations

13.

Talos, Flaminia, et al.. (2009). Brdm2—an aberrant hypomorphic p63 allele. Cell Death and Differentiation. 17(1). 184–186. 8 indexed citations

14.

Talos, Flaminia, et al.. (2009). The α/β carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 γ-like proteins. Cell Death and Differentiation. 16(8). 1108–1117. 27 indexed citations

15.

Palacios, Gustavo, Flaminia Talos, Alice Nemajerová, Ute M. Moll, & Oleksi Petrenko. (2008). E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression. Cell Cycle. 7(12). 1776–1781. 7 indexed citations

16.

Nemajerová, Alice, Flaminia Talos, Ute M. Moll, & Oleksi Petrenko. (2008). Rb function is required for E1A-induced S-phase checkpoint activation. Cell Death and Differentiation. 15(9). 1440–1449. 14 indexed citations

17.

Talos, Flaminia, Alice Nemajerová, Elsa R. Flores, Oleksi Petrenko, & Ute M. Moll. (2007). p73 Suppresses Polyploidy and Aneuploidy in the Absence of Functional p53. Molecular Cell. 27(4). 647–659. 68 indexed citations

18.

Talos, Flaminia, Oleksi Petrenko, Patricio Mena, & Ute M. Moll. (2005). Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo. Cancer Research. 65(21). 9971–9981. 64 indexed citations

19.

Talos, Flaminia, et al.. (2005). MIF loss impairs Myc-induced lymphomagenesis. Cell Death and Differentiation. 12(10). 1319–1328. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact